News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
297,198 Results
Type
Article (15793)
Company Profile (69)
Press Release (281332)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (108936)
Career Advice (502)
Deals (16609)
Drug Delivery (104)
Drug Development (37798)
Employer Resources (51)
FDA (6618)
Job Trends (6514)
News (159903)
Policy (14505)
Tag
2025 Best Places to Work (7)
2026 Best Places to Work (13)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
40 Under 40 (2)
Academia (533)
Accelerated approval (34)
ADA (16)
Adcomms (9)
Allergies (136)
Alliances (23645)
ALS (90)
Alzheimer's disease (603)
Antibody-drug conjugate (ADC) (243)
Approvals (7081)
Artificial intelligence (366)
ASCO (116)
Autoimmune disease (119)
Automation (27)
Bankruptcy (156)
Belgium (8)
Best Places to Work (4598)
BIO (26)
Biologics (52)
BIOSECURE Act (9)
Biosimilars (201)
BioSpace Insights (75)
Biotechnology (32)
Bispecific (14)
Bladder cancer (64)
Brain cancer (46)
Breast cancer (259)
Cancer (2192)
Cardiovascular disease (254)
Career advice (460)
Career pathing (16)
CAR-T (88)
CDC (11)
CDMO (101)
Celiac Disease (2)
Cell therapy (248)
Cervical cancer (25)
Clinical research (34098)
Collaboration (1169)
Commercialization (38)
Company closure (3)
Compensation (490)
Complete response letters (54)
COVID-19 (852)
CRISPR (69)
CRO (4)
C-suite (872)
Cystic fibrosis (68)
Data (3497)
Decentralized trials (2)
Denatured (19)
Depression (71)
Dermatology (45)
Diabetes (223)
Diagnostics (1754)
Digital health (23)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (217)
Drug pricing (126)
Drug shortages (16)
Duchenne muscular dystrophy (120)
Earnings (42979)
Editorial (25)
Employer branding (4)
Employer resources (47)
ESMO (124)
Events (41548)
Executive appointments (712)
Eye disease (4)
FDA (8535)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (4)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (697)
Gene editing (107)
Generative AI (38)
Gene therapy (252)
GLP-1 (591)
Government (1494)
Grass and pollen (4)
Guidances (287)
Healthcare (4331)
Hematology (80)
HIV (26)
Huntington's disease (19)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (73)
Immunology and inflammation (109)
Immuno-oncology (53)
Indications (142)
Infectious disease (972)
Inflammatory bowel disease (99)
Inflation Reduction Act (7)
Influenza (31)
Intellectual property (172)
Interviews (67)
IPO (6769)
IRA (33)
Job creations (2083)
Job search strategy (400)
JPM (29)
Kidney cancer (19)
Kidney disease (65)
Labor market (51)
Layoffs (232)
Leadership (18)
Legal (3494)
Licensing (83)
Liver cancer (29)
Longevity (19)
Lung cancer (306)
Lung diease (5)
Lymphoma (193)
Machine learning (17)
Management (18)
Manufacturing (776)
Marketing (22)
MASH (109)
Medical affairs (3)
Medical device (2008)
Medtech (2050)
Melanoma (60)
Mergers & acquisitions (10502)
Metabolic disorders (747)
Middle East (1)
mRNA (87)
Multiple sclerosis (75)
Multispecific (1)
NASH (15)
Netherlands (9)
Neurodegenerative disease (152)
Neuropsychiatric disorders (60)
Neuroscience (1292)
Neurotech (2)
NextGen: Class of 2026 (1715)
Non-profit (659)
Now hiring (31)
Obesity (388)
Opinion (167)
Ovarian cancer (86)
Pain (169)
Pancreatic cancer (90)
Parkinson's disease (130)
Partnered (17)
Patents (356)
Patient advocacy (1)
Patient recruitment (246)
Patient selection (33)
Peanut (35)
People (31037)
Peptides (20)
Pharmaceutical (34)
Pharmacy benefit managers (20)
Phase 1 (8850)
Phase 2 (14372)
Phase 3 (13031)
Pipeline (5930)
Policy (167)
Postmarket research (1420)
Preclinical (3609)
Press Release (26)
Prostate cancer (137)
Psychedelics (33)
Radioligand (1)
Radiopharmaceuticals (197)
Rare diseases (625)
Real estate (2693)
Recruiting (19)
Regenerative medicine (9)
Regulatory (12262)
Reports (26)
Research institute (634)
Resumes & cover letters (60)
Rett syndrome (20)
RNA editing (10)
RSV (29)
Saudi Arabia (1)
Schizophrenia (107)
Series A (139)
Series B (77)
Series C (1)
Service/supplier (1)
Sickle cell disease (70)
Special edition (15)
Spinal muscular atrophy (86)
Sponsored (14)
Startups (1688)
State (2)
Stem cells (2)
Stomach cancer (8)
Substance use disorders (10)
Supply chain (78)
Switzerland (13)
Tariffs (73)
The Weekly (57)
Vaccines (327)
Venture capital (58)
Weight loss (218)
Wet AMD (4)
Women's health (75)
Worklife (5)
Date
Today (6)
Last 7 days (240)
Last 30 days (1378)
Last 365 days (11610)
2026 (10725)
2025 (11613)
2024 (13490)
2023 (15461)
2022 (20851)
2021 (21270)
2020 (20171)
2019 (15804)
2018 (12491)
2017 (14424)
2016 (13642)
2015 (16111)
2014 (12931)
2013 (10896)
2012 (11704)
2011 (12321)
2010 (11240)
Location
Africa (334)
Alabama (26)
Alaska (1)
Arizona (119)
Arkansas (4)
Asia (22289)
Australia (2872)
California (5170)
Canada (2245)
China (992)
Colorado (238)
Connecticut (251)
Delaware (216)
Europe (44665)
Florida (970)
Georgia (122)
Hawaii (2)
Idaho (11)
Illinois (581)
India (105)
Indiana (415)
Iowa (4)
Japan (461)
Kansas (94)
Kentucky (24)
Louisiana (23)
Maine (7)
Maryland (641)
Massachusetts (4051)
Michigan (80)
Minnesota (279)
Mississippi (3)
Missouri (54)
Montana (12)
Nebraska (8)
Nevada (28)
New Hampshire (17)
New Jersey (2252)
New Mexico (7)
New York (1476)
North Carolina (937)
North Dakota (2)
Northern California (2543)
Ohio (144)
Oklahoma (6)
Oregon (17)
Pennsylvania (1133)
Puerto Rico (24)
Rhode Island (19)
South America (523)
South Carolina (17)
Southern California (2272)
Tennessee (90)
Texas (752)
United States (20453)
Utah (116)
Vermont (1)
Virginia (299)
Washington D.C. (43)
Washington State (405)
West Virginia (1)
Wisconsin (84)
Wyoming (2)
297,198 Results for "intas pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India
February 10, 2026
·
3 min read
Press Releases
Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
March 23, 2026
·
5 min read
Intas & Accord signs Agreement to acquire Prothya Biosolutions
August 12, 2025
·
3 min read
Press Releases
Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada
October 10, 2025
·
6 min read
Policy
Cancer Drug Manufacturer Intas Slapped with FDA Warning Letter
Following reports of destroyed and discarded data, the U.S. regulator issued a warning letter to India’s Intas Pharmaceuticals regarding violations of current good manufacturing practice.
August 2, 2023
·
2 min read
·
Tristan Manalac
Business
Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited (“Intas”) for the development and commercialisation in Europe and India for several indications including ES-SCLC, and specific formulation of HANSIZHUANG (serplulimab injection), Henlius’ novel anti-PD-1 mAb.
October 27, 2023
·
10 min read
Press Releases
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
December 3, 2024
·
15 min read
Genetown
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration
Today, Comera Life Sciences, Inc. (“Comera” or the “Company”) and Intas Pharmaceuticals Ltd. (“Intas”) announced a research collaboration to develop a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience.
April 19, 2022
·
9 min read
Press Releases
Bio-Thera Solutions Announces Exclusive Commercialization and License Agreement with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), in the United States of America
February 10, 2025
·
6 min read
Press Releases
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 3, 2024
·
8 min read
1 of 29,720
Next